Oregon will receive nearly four million dollars from a multi-state settlement with the pharmaceutical company GlaxoSmithKline.
The settlement follows allegations that GlaxoSmithKline unlawfully promoted and misrepresented its asthma drug—Advair and a couple of antidepressants—Paxil and Wellbutrin.
Attorney General Ellen Rosenblum, along with 44 other attorneys general, was involved in reaching a $105-million settlement with the company. GlaxoSmithKline does not admit to the allegations, but in the settlement agrees to reform its marketing and promotion of the drugs.
David Hart is an Oregon assistant attorney general who helped with the case.
“The Attorney General Rosenblum will aggressively protect consumers using our laws against deceptive drug marketing and promotion.”
Hart says this is the third multi-state consumer protection settlement that Oregon’s attorney general led against the pharmaceutical company. He says overall the state has recovered more than sixteen million dollars from GSK.
Other states involved in the settlement include California, Washington, and Idaho.